Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Zachary D. Wallen, Ayşe Demirkan, Guy Twa, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 192

Showing 26-50 of 192 citing articles:

Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
Yi Zhang, Chengjun Mo, Penghui Ai, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Lewy body diseases and the gut
Timothy R. Sampson, Malú G. Tansey, Andrew B. West, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Alpha synuclein overexpression can drive microbiome dysbiosis in mice
Timothy R. Sampson, Zachary D. Wallen, Woong-Jai Won, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
The Inflammatory Mechanism of Parkinson’s Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut–Brain Axis
Ai Gao, Jiaqi Lv, Yanwei Su
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 159-159
Open Access | Times Cited: 1
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Vicky Yao, Nairui Fan, Shuxia Ma, et al.
MedComm (2025) Vol. 6, Iss. 5
Open Access | Times Cited: 1
Advances in the integration of metabolomics and metagenomics for human gut microbiome and their clinical applications
Francesc Puig‐Castellví, Romina Pacheco‐Tapia, Maxime Deslande, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 167, pp. 117248-117248
Open Access | Times Cited: 20
Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease
Yogesh Singh, Christoph Trautwein, J. Romaní, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 19
Central and peripheral innate and adaptive immunity in Parkinson’s disease
Ashley S. Harms, Yating Yang, Malú G. Tansey
Science Translational Medicine (2023) Vol. 15, Iss. 721
Closed Access | Times Cited: 18
Exploring the Mechanistic Interplay between Gut Microbiota and Precocious Puberty: A Narrative Review
Min Yue, Lei Zhang
Microorganisms (2024) Vol. 12, Iss. 2, pp. 323-323
Open Access | Times Cited: 8
Interpretation of vaginal metagenomic characteristics in different types of vaginitis
Jiarong Song, Xue Dong, Yue Lan, et al.
mSystems (2024) Vol. 9, Iss. 3
Open Access | Times Cited: 8
Gut Microbial Metabolome and Dysbiosis in Neurodegenerative Diseases: Psychobiotics and Fecal Microbiota Transplantation as a Therapeutic Approach—A Comprehensive Narrative Review
Sara Uceda, Víctor Echeverry‐Alzate, Manuel Reiriz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13294-13294
Open Access | Times Cited: 14
Serum Amyloid A3 Fuels a Feed-Forward Inflammatory Response to the Bacterial Amyloid Curli in the Enteric Nervous System
Peter Verstraelen, Samuel Van Remoortel, Nouchin De Loose, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 1, pp. 89-104
Open Access | Times Cited: 6
Correlating the Gut Microbiome to Health and Disease
Tatiana M. Marques, John Peter Ganda-Mall, Richard A. Forsgård, et al.
Elsevier eBooks (2024), pp. 1-36
Closed Access | Times Cited: 5
Integration of polygenic and gut metagenomic risk prediction for common diseases
Yang Liu, Scott C. Ritchie, Shu Mei Teo, et al.
Nature Aging (2024) Vol. 4, Iss. 4, pp. 584-594
Open Access | Times Cited: 5
The molecular interplay between human and bacterial amyloids: Implications in neurodegenerative diseases
Neha Jain
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2024) Vol. 1872, Iss. 4, pp. 141018-141018
Closed Access | Times Cited: 5
The Role of the Gut Microbiome in Health and Disease in the Elderly
Lea Ann Chen, Kaitlyn Boyle
Current Gastroenterology Reports (2024) Vol. 26, Iss. 9, pp. 217-230
Open Access | Times Cited: 5
TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity
Miriam Langguth, Eleftheria Maranou, Saara A. Koskela, et al.
Genes and Immunity (2024) Vol. 25, Iss. 3, pp. 188-200
Open Access | Times Cited: 5
Rapid species-level metagenome profiling and containment estimation with sylph
Jim Shaw, Yun William Yu
Nature Biotechnology (2024)
Open Access | Times Cited: 5
Immune mechanisms and shared immune targets in neurodegenerative diseases
Howard L. Weiner
Nature Reviews Neurology (2024)
Closed Access | Times Cited: 5
Role of Microbiota-Modified Bile Acids in the Regulation of Intracellular Organelles and Neurodegenerative Diseases
Yoshimitsu Kiriyama, Hiromi Nochi
Genes (2023) Vol. 14, Iss. 4, pp. 825-825
Open Access | Times Cited: 13
Differences in the gut microbiome across typical ageing and in Parkinson's disease
Nathan D. Nuzum, Ewa A. Szymlek‐Gay, Stella Loke, et al.
Neuropharmacology (2023) Vol. 235, pp. 109566-109566
Closed Access | Times Cited: 13
Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders
Francisca Villavicencio-Tejo, Margrethe A. Olesen, Laura Navarro, et al.
Neurotoxicity Research (2023) Vol. 42, Iss. 1
Closed Access | Times Cited: 13
The Role of an Altered Gut Microbiome in Parkinson’s Disease: A Narrative Review
Sara Hashish, Mohamed Salama
Applied Microbiology (2023) Vol. 3, Iss. 2, pp. 429-447
Open Access | Times Cited: 12
Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice
Xizhen Ma, Leilei Chen, Le Qu, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 1, pp. 52-65
Closed Access | Times Cited: 12
Unveiling metabotype clustering in resveratrol, daidzein, and ellagic acid metabolism: Prevalence, associated gut microbiomes, and their distinctive microbial networks
Carlos E. Iglesias‐Aguirre, María Romo‐Vaquero, María V. Selma, et al.
Food Research International (2023) Vol. 173, pp. 113470-113470
Open Access | Times Cited: 12

Scroll to top